2
Clinical Trials associated with Anti-CD22-CAR-transduced T cells(Southwest Hospital) / Unknown statusPhase 1/2IIT A Clinical Research of BCMA-Targeted CAR-T in B Cell Malignancies
The overall purpose of this study is to explore the therapeutic effect of BCMA-targeted chimeric antigen receptor T(CAR-T) cells in the treatment of B-cell derived malignancies.
/ Unknown statusPhase 1/2IIT A Clinical Research of CD22-Targeted CAR-T in B Cell Malignancies
The overall purpose of this study is to explore the therapeutic effect of CD22-targeted chimeric antigen receptor T(CAR-T) cells in the treatment of Malignant B-cell Derived Leukemia and Lymphoma.
100 Clinical Results associated with Anti-CD22-CAR-transduced T cells(Southwest Hospital)
100 Translational Medicine associated with Anti-CD22-CAR-transduced T cells(Southwest Hospital)
100 Patents (Medical) associated with Anti-CD22-CAR-transduced T cells(Southwest Hospital)
100 Deals associated with Anti-CD22-CAR-transduced T cells(Southwest Hospital)